Cargando…
Deficient Lmna in fibroblasts: an emerging role of non-cardiomyocytes in DCM
Autores principales: | Wang, Xinjie, Luo, Weijia, Chang, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450693/ https://www.ncbi.nlm.nih.gov/pubmed/36082133 http://dx.doi.org/10.20517/jca.2022.26 |
Ejemplares similares
-
Personalized Medicine Approach in a DCM Patient with LMNA Mutation Reveals Dysregulation of mTOR Signaling
por: Neupane, Balram, et al.
Publicado: (2022) -
Identification of a LMNA (c.646C>T) variant by whole-exome sequencing in combination with a dilated cardiomyopathy (DCM) related gene filter in a family with familiar DCM
por: Chen, Liang, et al.
Publicado: (2018) -
Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
por: Onoue, Kenji, et al.
Publicado: (2021) -
Phenotypic Variability in iPSC-Induced Cardiomyocytes and Cardiac Fibroblasts Carrying Diverse LMNA Mutations
por: Yang, Jiajia, et al.
Publicado: (2021) -
Genotype Complements the Phenotype: Identification of the Pathogenicity of an LMNA Splice Variant by Nanopore Long-Read Sequencing in a Large DCM Family
por: Sedaghat-Hamedani, Farbod, et al.
Publicado: (2022)